ArticleMolecular therapy. Methods & clinical development2020

A Novel Proteomic Method Reveals NLS Tagging of T-DM1 Contravenes Classical Nuclear Transport in a Model of HER2-Positive Breast Cancer.

Vincent Lacasse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.